Inari Medical, Inc.
NARI · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $2 | $3 | $3 | $4 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $3 | $3 | $4 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 5.2% | 1.8% | 8.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 87.1% | 83.9% | 86.8% | 86.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4.7% | -11.4% | -8% | -0.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -12% | -21.5% | -16.9% | -3.5% |
| EPS Diluted | -0.31 | -0.54 | -0.42 | -0.081 |
| % Growth | 42.6% | -28.6% | -418.5% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | $0 |